BR9814199A - Utilização dos quetólidos para prevenir as complicações trombóticas arteriais ligadas à aterosclerose - Google Patents

Utilização dos quetólidos para prevenir as complicações trombóticas arteriais ligadas à aterosclerose

Info

Publication number
BR9814199A
BR9814199A BR9814199-6A BR9814199A BR9814199A BR 9814199 A BR9814199 A BR 9814199A BR 9814199 A BR9814199 A BR 9814199A BR 9814199 A BR9814199 A BR 9814199A
Authority
BR
Brazil
Prior art keywords
atherosclerosis
thrombotic complications
ketolides
complications related
arterial thrombotic
Prior art date
Application number
BR9814199-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Francis Petit
Francoise Vacheron
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of BR9814199A publication Critical patent/BR9814199A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BR9814199-6A 1997-11-17 1998-11-16 Utilização dos quetólidos para prevenir as complicações trombóticas arteriais ligadas à aterosclerose BR9814199A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714358A FR2771008B1 (fr) 1997-11-17 1997-11-17 Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
PCT/FR1998/002436 WO1999025365A1 (fr) 1997-11-17 1998-11-16 Utilisation des ketolides pour prevenir les complications thrombotiques arterielles liees a l'atherosclerose

Publications (1)

Publication Number Publication Date
BR9814199A true BR9814199A (pt) 2000-09-26

Family

ID=9513423

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9814199-6A BR9814199A (pt) 1997-11-17 1998-11-16 Utilização dos quetólidos para prevenir as complicações trombóticas arteriais ligadas à aterosclerose

Country Status (35)

Country Link
US (1) US20080139489A1 (https=)
EP (1) EP1030673B1 (https=)
JP (1) JP4550273B2 (https=)
KR (1) KR20010032130A (https=)
CN (1) CN1286633A (https=)
AP (1) AP1196A (https=)
AR (1) AR014119A1 (https=)
AT (1) ATE271875T1 (https=)
AU (1) AU744419B2 (https=)
BG (1) BG104427A (https=)
BR (1) BR9814199A (https=)
CA (1) CA2312021C (https=)
DE (1) DE69825308T2 (https=)
DZ (1) DZ2654A1 (https=)
EA (1) EA003322B1 (https=)
EE (1) EE04095B1 (https=)
ES (1) ES2224446T3 (https=)
FR (1) FR2771008B1 (https=)
GE (1) GEP20032968B (https=)
HR (1) HRP20000314A2 (https=)
HU (1) HUP0004507A3 (https=)
ID (1) ID24940A (https=)
IL (1) IL136149A0 (https=)
MA (1) MA26566A1 (https=)
NO (1) NO20002435L (https=)
NZ (1) NZ504305A (https=)
OA (1) OA11411A (https=)
PL (1) PL340373A1 (https=)
SK (1) SK7042000A3 (https=)
TN (1) TNSN98206A1 (https=)
TR (1) TR200001384T2 (https=)
TW (1) TW472061B (https=)
WO (1) WO1999025365A1 (https=)
YU (1) YU29600A (https=)
ZA (1) ZA9810357B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777282B1 (fr) * 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
TR200102129T2 (tr) 1998-12-10 2002-01-21 Pfizer Products Inc. Karbamat ve karbazat ketolid antibiyotikleri.
CA2359708C (en) * 1999-01-27 2005-10-25 Pfizer Products Inc. Ketolide antibiotics
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
KR100758441B1 (ko) 2000-04-04 2007-09-14 스미스클라인비이참피이엘시이 항균제용 2―히드록시―무틸린 카르바메이트 유도체
JP2004323414A (ja) * 2003-04-24 2004-11-18 Japan Science & Technology Agency １４員環マクロライド化合物を利用した、血管平滑筋の増殖に起因する疾患治療剤
GB0402578D0 (en) * 2004-02-05 2004-03-10 Cambridge Theranostics Ltd Methods of treatment of atherosclerosis
EP2613630A4 (en) * 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424187A (en) * 1991-06-14 1995-06-13 Board Of Regents Of The University Of Washington Method of screening for arterial chlamydial granuloma
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
GB9621771D0 (en) * 1996-10-18 1996-12-11 St George S Enterprises Ltd Method of treatment of heart disease
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics

Also Published As

Publication number Publication date
EP1030673B1 (fr) 2004-07-28
IL136149A0 (en) 2001-05-20
CA2312021A1 (fr) 1999-05-27
ES2224446T3 (es) 2005-03-01
FR2771008B1 (fr) 2000-04-28
YU29600A (sh) 2003-02-28
US20080139489A1 (en) 2008-06-12
AU744419B2 (en) 2002-02-21
EP1030673A1 (fr) 2000-08-30
AR014119A1 (es) 2001-02-07
ID24940A (id) 2000-08-31
JP4550273B2 (ja) 2010-09-22
AU1242599A (en) 1999-06-07
SK7042000A3 (en) 2000-12-11
TNSN98206A1 (fr) 2005-03-15
GEP20032968B (en) 2003-05-27
EE04095B1 (et) 2003-08-15
AP2000001825A0 (en) 2000-06-30
NO20002435L (no) 2000-07-07
DZ2654A1 (fr) 2003-03-22
BG104427A (en) 2001-02-28
CA2312021C (fr) 2008-08-26
HUP0004507A3 (en) 2001-12-28
AP1196A (en) 2003-08-18
KR20010032130A (ko) 2001-04-16
EA003322B1 (ru) 2003-04-24
WO1999025365A1 (fr) 1999-05-27
JP2001523644A (ja) 2001-11-27
ZA9810357B (en) 1999-11-12
NZ504305A (en) 2002-11-26
ATE271875T1 (de) 2004-08-15
NO20002435D0 (no) 2000-05-11
DE69825308T2 (de) 2005-08-04
TW472061B (en) 2002-01-11
DE69825308D1 (de) 2004-09-02
HUP0004507A1 (hu) 2001-05-28
CN1286633A (zh) 2001-03-07
HRP20000314A2 (en) 2001-02-28
PL340373A1 (en) 2001-01-29
OA11411A (fr) 2004-04-20
MA26566A1 (fr) 2004-12-20
TR200001384T2 (tr) 2001-06-21
FR2771008A1 (fr) 1999-05-21
EE200000244A (et) 2001-06-15
EA200000531A1 (ru) 2000-10-30

Similar Documents

Publication Publication Date Title
BR9711194A (pt) Uso de agente quelante clioquinol para a fabricação de uma composição farmacêutica para o tratamento de doença de alzheimer.
BR9814327A (pt) Compostos de tiouréia e benzamida, composições e pro-cessos para tratamento ou prevenção de doenças infla-matórias e arteriosclerose
ES2189256T3 (es) Composiciones de mezclas de ester de cianoacrilato.
BR9808948A (pt) Composição de confeitaria
BR9810312A (pt) Composição farmacêutica que apresenta atividade antitumoral acentuada e/ou efeitos colaterais reduzidos contendo um agente antitumoral e um derivado do ácido hidroxìmico
BR9914044A (pt) ésteres tetrahidropirido
BRPI9710372B8 (pt) composto, e, composição farmacêutica.
BR9804437A (pt) Compostos para a osteoporose
BR9813028A (pt) Agonistas de prostaglandina e seu uso para tratar distúrbios nos ossos
IS4695A (is) (Metýlsúlfónýl)fenýl-2-(5H)-fúranón sem sýklóoxýgenasa-2 tálmar
GB0129260D0 (en) Pharmaceutical compositions and their uses
ATE221879T1 (de) Kristalline paclitaxel hydrate
BR9406509A (pt) Compostos processo sua preparação uso dos mesmos composições farmaceuticas e processo para profilaxia e para tratamento terapeutico de malária e doenças causadas por leishmania toxoplasma gondil pneumocy
BR9808302A (pt) O uso de levobupivacaìna na cirurgia pediátrica
CA2340224A1 (en) Nimesulide containing topical pharmaceutical compositions
BR9814199A (pt) Utilização dos quetólidos para prevenir as complicações trombóticas arteriais ligadas à aterosclerose
BR9911884A (pt) Preparação farmacêutica
BR9804753A (pt) Compostos de ácido picolìnico 5-substituìdo e processos para a sua produção.
AU4179399A (en) Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
BR9812780A (pt) 2-aril-3-aroilbenzo[b]tiofenos úteis para o tratamento de sìndrome da perda de estrogênio
CA2244134A1 (en) Diphenyl stilbenes as prodrugs to cox-2 inhibitors
BR9912816A (pt) Composição terapêutica à base de flavonóides, tencionada para uso no tratamento de tumores por agentes citotóxicos
HUP9902135A2 (hu) (+)-alfa-(2,3-Dimetoxi-fenil)-1-[2-(4-fluor-fenil)-etil]-4-piperidin-metanol alkalmazása depresszív és bipoláris rendellenességek kezelésére alkalmas gyógyszerkészítmény előállítására
BR9911005A (pt) Uso de ozÈnio para a preparação de medicamentos para o tratamento de cáries dentárias
BR0007183A (pt) Isonipectoamidas para o tratamento de distúrbios mediados por integrina

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: AVENTIS PHARMA S.A. (FR)

Free format text: TRANSFERIDO POR FUSAO DE: HOECHST MARION ROUSSEL

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 31/35, A61K 31/53, A61K 31/7042, A61K 70/48, A61K 7/00, A61K 9/00, C07H 17/08

Ipc: A61K 31/70 (2008.04)

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO DE PATENTE, UMA VEZ QUE O RELATORIO NAO DESCREVE CLARA E SUFICIENTEMENTE O OBJETO, DE MODO A POSSIBILITAR SUA REALIZACAO POR UM TECNICO NO ASSUNTO (...) ( ART. 24 DA LPI ), AS REIVINDICACAOES NAO ESTAO FUNDAMENTADA NO RELATORIO DESCRITIVO, TAMPOUCO DEFINEM, DE MODO CLARO E PRECISO, A MATERIA OBJETO DE PROTECAO ( ART. 25 DA LPI )

B12B Appeal against refusal [chapter 12.2 patent gazette]